About this trial
Pulmonary dysfunction can be developed as a result of complications caused by direct thermal injury to the respiratory tract, smoke irritations, and respiratory tract infection. Although the survival rates of patients with burn injury have increased because of improved acute management, pulmonary complications have continued to be the main cause of mortality in patients with burns. The patients who survive suffer from persistent physiological impairments, limited aerobic capacity, increased skeletal muscle catabolism, and decreased muscle strength/endurance. Rehabilitation strategies for the long-term recovery in patients with burns aim to improve the physical function and independence in daily activities.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Participants with inhalation injury after thermal burn injury including face and chest
with 40-60 % of total body surface area (%TBSA)
Partial or full thickness burns that either recovered spontaneously or healed by skin grafting
Age (20-50) years.
Disqualifiers
Cerebrovascular disease
Heavy smokers
Open or unhealed wounds
Chest physical therapy before enrollment
Trial design
Parallel
Treatments tested in this trial
Inspiratory muscle training
DeviceParticipants in the experimental group will receive Inspiratory muscle training device, in addition to conventional physical therapy program. Initially, participants will be asked to perform three sets of 30 breaths on the POWER breathe to adjust the load and become familiar with the device. The training will include six 30-breath sets each day, divided into two sessions each. There is a one-minute rest time between each set. The inspiratory muscle load for training will be 50% of maximum inspiratory pressure (MIP), and it will be reviewed and changed weekly.
Conventional physical therapy
Other interventionConventional physical therapy exercise program in the form of respiratory physical therapy, balance and aerobic exercises.
Treatment groups
Trial outcomes
Primary outcomes
Respiratory muscle strength (Maximum Inspiratory Pressure)
Maximum Inspiratory Pressure (MIP): Inspiratory muscle strength will be assessed by measuring the maximum inspiratory pressure (MIP) using a respiratory pressure meter. MIP will be recorded in cmH₂O, with higher values indicating greater inspiratory muscle strength.
Secondary outcomes
Respiratory muscle strength (Maximum expiratory Pressure)
Maximum Expiratory Pressure (MEP): Expiratory muscle strength will be assessed by measuring the maximum expiratory pressure (MEP) using a respiratory pressure meter. MEP will be recorded in cmH₂O, with higher values indicating greater expiratory muscle strength.
Balance
Static and dynamic balance of the participants will be assessed through the Berg Balance Scale (BBS) where the patient has to perform 14 predetermined physical tasks assessing different aspects of balance. These include static, anticipatory, dynamic and sensory balance. Each task will be scored from 0 to 4 where 4 indicates the person can complete the task independently with a final maximal score of 56. Higher scores indicate better balance performance.
Postural stability (Overall Stability Index)
Overall Stability Index (OSI): Postural stability will be assessed using the Biodex Postural Stability System (Biodex Medical Systems, Shirley, NY, USA). The Overall Stability Index (OSI) will be recorded as an indicator of overall postural stability, with lower values indicating better stability.
Postural stability (Anterior-Posterior Index)
Anterior-Posterior Index (API): The Anterior-Posterior Stability Index (API) will be measured using the Biodex Postural Stability System (Biodex Medical Systems, Shirley, NY, USA) to assess postural stability in the anterior-posterior direction. Lower values indicate better stability.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: